STAT+: Amylyx is breaking all of biotech’s unwritten rules — and still raising impressive sums
If you want to raise big money in biotech, there are a few unwritten rules.
You need a partnership with an established pharmaceutical company. You need an idea that gives you more than one shot at finding something that works. And you need seasoned executives or serial entrepreneurs at the helm.
Continue to STAT+ to read the full story…
